Annual SGA
$9.96 M
+$128.00 K+1.30%
December 31, 2023
Summary
- As of February 8, 2025, RGLS annual SGA is $9.96 million, with the most recent change of +$128.00 thousand (+1.30%) on December 31, 2023.
- During the last 3 years, RGLS annual SGA has risen by +$1.14 million (+12.97%).
- RGLS annual SGA is now -47.95% below its all-time high of $19.13 million, reached on December 31, 2015.
Performance
RGLS SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$3.86 M
-$88.00 K-2.23%
September 30, 2024
Summary
- As of February 8, 2025, RGLS quarterly SGA is $3.86 million, with the most recent change of -$88.00 thousand (-2.23%) on September 30, 2024.
- Over the past year, RGLS quarterly SGA has dropped by -$88.00 thousand (-2.23%).
- RGLS quarterly SGA is now -45.26% below its all-time high of $7.06 million, reached on June 30, 2017.
Performance
RGLS Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$2.11 B
-$41.63 M-2.01%
September 30, 2024
Summary
- As of February 8, 2025, RGLS TTM SGA is -$2.11 billion, with the most recent change of -$41.63 million (-2.01%) on September 30, 2024.
- Over the past year, RGLS TTM SGA has dropped by -$2.13 billion (-17851.60%).
- RGLS TTM SGA is now -4815.94% below its all-time high of -$43.01 million.
Performance
RGLS TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
RGLS Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.3% | -2.2% | -10000.0% |
| 3 y3 years | +13.0% | +56.6% | -10000.0% |
| 5 y5 years | -22.6% | +50.3% | -10000.0% |
RGLS Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.7% | +1.3% | -2.2% | +74.1% | -19.1% | at low |
| 5 y | 5-year | -12.0% | +13.0% | -2.2% | +87.6% | -30.9% | at low |
| alltime | all time | -48.0% | +173.8% | -45.3% | +399.7% | -4815.9% | at low |
Regulus Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $3.86 M(-2.2%) | $13.14 M(+10.3%) |
| Jun 2024 | - | $3.95 M(+41.8%) | $11.91 M(+15.7%) |
| Mar 2024 | - | $2.79 M(+9.8%) | $10.30 M(+3.4%) |
| Dec 2023 | $9.96 M(+1.3%) | $2.54 M(-3.8%) | $9.96 M(+3.3%) |
| Sep 2023 | - | $2.64 M(+12.7%) | $9.64 M(+4.1%) |
| Jun 2023 | - | $2.34 M(-4.3%) | $9.26 M(-1.4%) |
| Mar 2023 | - | $2.44 M(+10.1%) | $9.38 M(-4.5%) |
| Dec 2022 | $9.83 M(-1.9%) | $2.22 M(-1.5%) | $9.83 M(-3.3%) |
| Sep 2022 | - | $2.25 M(-8.7%) | $10.16 M(-2.4%) |
| Jun 2022 | - | $2.47 M(-14.6%) | $10.41 M(-0.2%) |
| Mar 2022 | - | $2.89 M(+13.3%) | $10.43 M(+4.1%) |
| Dec 2021 | $10.02 M(+13.7%) | $2.55 M(+1.9%) | $10.02 M(+5.0%) |
| Sep 2021 | - | $2.50 M(+0.6%) | $9.55 M(+4.9%) |
| Jun 2021 | - | $2.49 M(+0.4%) | $9.10 M(+2.6%) |
| Mar 2021 | - | $2.48 M(+19.2%) | $8.87 M(+0.6%) |
| Dec 2020 | $8.81 M(-22.1%) | $2.08 M(+0.9%) | $8.81 M(-3.1%) |
| Sep 2020 | - | $2.06 M(-8.7%) | $9.10 M(-5.3%) |
| Jun 2020 | - | $2.25 M(-6.9%) | $9.61 M(-5.8%) |
| Mar 2020 | - | $2.42 M(+2.5%) | $10.21 M(-9.8%) |
| Dec 2019 | $11.32 M(-12.0%) | $2.36 M(-8.1%) | $11.32 M(-3.3%) |
| Sep 2019 | - | $2.57 M(-9.8%) | $11.70 M(-3.5%) |
| Jun 2019 | - | $2.85 M(-19.3%) | $12.12 M(-4.0%) |
| Mar 2019 | - | $3.53 M(+28.7%) | $12.62 M(-1.9%) |
| Dec 2018 | $12.86 M(-24.4%) | $2.75 M(-8.3%) | $12.86 M(-3.8%) |
| Sep 2018 | - | $2.99 M(-10.6%) | $13.37 M(+2.0%) |
| Jun 2018 | - | $3.35 M(-11.2%) | $13.12 M(-22.0%) |
| Mar 2018 | - | $3.77 M(+15.8%) | $16.82 M(-1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $17.01 M(-7.5%) | $3.26 M(+19.1%) | $17.01 M(-8.2%) |
| Sep 2017 | - | $2.74 M(-61.2%) | $18.53 M(-10.2%) |
| Jun 2017 | - | $7.06 M(+78.3%) | $20.64 M(+19.7%) |
| Mar 2017 | - | $3.96 M(-17.2%) | $17.25 M(-6.2%) |
| Dec 2016 | $18.39 M(-3.9%) | $4.78 M(-1.2%) | $18.39 M(-3.4%) |
| Sep 2016 | - | $4.84 M(+32.2%) | $19.04 M(+3.2%) |
| Jun 2016 | - | $3.66 M(-28.2%) | $18.44 M(-10.4%) |
| Mar 2016 | - | $5.10 M(-6.0%) | $20.59 M(+7.6%) |
| Dec 2015 | $19.13 M(+65.9%) | $5.43 M(+27.8%) | $19.13 M(+12.7%) |
| Sep 2015 | - | $4.25 M(-27.0%) | $16.98 M(+11.0%) |
| Jun 2015 | - | $5.81 M(+59.5%) | $15.30 M(+23.0%) |
| Mar 2015 | - | $3.64 M(+11.2%) | $12.45 M(+7.9%) |
| Dec 2014 | $11.53 M(+55.2%) | $3.28 M(+27.6%) | $11.53 M(+13.7%) |
| Sep 2014 | - | $2.57 M(-13.0%) | $10.14 M(+6.9%) |
| Jun 2014 | - | $2.95 M(+8.1%) | $9.49 M(+14.9%) |
| Mar 2014 | - | $2.73 M(+45.0%) | $8.26 M(+11.1%) |
| Dec 2013 | $7.43 M(+50.6%) | $1.88 M(-1.7%) | $7.43 M(-0.7%) |
| Sep 2013 | - | $1.92 M(+11.3%) | $7.48 M(+12.4%) |
| Jun 2013 | - | $1.72 M(-9.6%) | $6.66 M(+12.5%) |
| Mar 2013 | - | $1.91 M(-1.5%) | $5.92 M(+20.0%) |
| Dec 2012 | $4.93 M(+35.6%) | $1.93 M(+76.9%) | $4.93 M(+30.8%) |
| Sep 2012 | - | $1.09 M(+11.1%) | $3.77 M(+5.2%) |
| Jun 2012 | - | $984.00 K(+6.8%) | $3.58 M(+37.8%) |
| Mar 2012 | - | $921.00 K(+19.1%) | $2.60 M(+54.8%) |
| Dec 2011 | $3.64 M(-7.2%) | $773.00 K(-14.8%) | $1.68 M(+85.2%) |
| Sep 2011 | - | $907.00 K | $907.00 K |
| Dec 2010 | $3.92 M | - | - |
FAQ
- What is Regulus Therapeutics annual SGA?
- What is the all time high annual SGA for Regulus Therapeutics?
- What is Regulus Therapeutics annual SGA year-on-year change?
- What is Regulus Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Regulus Therapeutics?
- What is Regulus Therapeutics quarterly SGA year-on-year change?
- What is Regulus Therapeutics TTM SGA?
- What is the all time high TTM SGA for Regulus Therapeutics?
- What is Regulus Therapeutics TTM SGA year-on-year change?
What is Regulus Therapeutics annual SGA?
The current annual SGA of RGLS is $9.96 M
What is the all time high annual SGA for Regulus Therapeutics?
Regulus Therapeutics all-time high annual SGA is $19.13 M
What is Regulus Therapeutics annual SGA year-on-year change?
Over the past year, RGLS annual SGA has changed by +$128.00 K (+1.30%)
What is Regulus Therapeutics quarterly SGA?
The current quarterly SGA of RGLS is $3.86 M
What is the all time high quarterly SGA for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly SGA is $7.06 M
What is Regulus Therapeutics quarterly SGA year-on-year change?
Over the past year, RGLS quarterly SGA has changed by -$88.00 K (-2.23%)
What is Regulus Therapeutics TTM SGA?
The current TTM SGA of RGLS is -$2.11 B
What is the all time high TTM SGA for Regulus Therapeutics?
Regulus Therapeutics all-time high TTM SGA is -$43.01 M
What is Regulus Therapeutics TTM SGA year-on-year change?
Over the past year, RGLS TTM SGA has changed by -$2.13 B (-17851.60%)